Baxion
Screening
Tags
Alerts
Theme
Ocular Therapeutix, Inc.
OCUL
·
NASDAQ
·
$8.29
Share Price as of 11/2
·
$2B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/03/26
10-Q
Q1 ended 03/31/26
05/05/26
10-K
FY 2025
02/05/26
10-Q
Q3 ended 09/30/25
11/04/25
10-Q
Q2 ended 06/30/25
08/05/25
Disclosures
Filter
8-K
Current report
10/16/26
8-K
Current report
08/03/26
8-K
Current report
06/12/26
8-K
Current report
05/05/26
8-K
Current report
02/27/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
08/03/26
S-8
Registration of securities for employees
02/05/26
424B5
Prospectus supplement
09/30/25
S-3ASR
Automatic shelf registration
09/30/25
S-8
Registration of securities for employees
06/11/25
Proxies
Filter
DEF 14A
Definitive proxy
04/30/26
DEFA14A
Additional proxy materials
04/30/26
DEF 14A
Definitive proxy
04/29/25
DEFA14A
Additional proxy materials
04/29/25
PRE 14A
Preliminary proxy
04/18/25
Ownership
Filter
Form 4
Insider transaction
10/13/26
144
Proposed sale of securities
10/08/26
Form 4
Insider transaction
10/06/26
Form 4
Insider transaction
10/06/26
144
Proposed sale of securities
10/02/26
Other
Filter
ARS
Annual report to shareholders
04/30/26
ARS
Annual report to shareholders
04/29/25
ARS
Annual report to shareholders
04/29/24
EFFECT
Request for effectiveness
11/16/23
CORRESP
Correspondence with the SEC
11/14/23
Latest Filings
Filter
8-K
Current report
10/16/26
10-Q
Q2 ended 06/30/26
08/03/26
8-K
Current report
08/03/26
S-8
Registration of securities for employees
08/03/26
8-K
Current report
06/12/26
Ownership
Filter
Form 4
Insider transaction
10/13/26
144
Proposed sale of securities
10/08/26
Form 4
Insider transaction
10/06/26
Form 4
Insider transaction
10/06/26
144
Proposed sale of securities
10/02/26